DSpace at RU >

Browsing by Author Mouton, J.W.

Full Text	Issue Date	Title	Author(s)
	2011	Clinical impact of preincubation of blood cultures at 37 degrees C.	Velden, L.B. van der; Vos, F.J.; Mouton, J.W.; Sturm, P.D.J.
	2011	Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective	Mouton, J.W.; Ambrose, P.G.; Canton, R.; Drusano, G.L.; Harbarth, S., et al
	2011	Method for phenotypic detection of extended-spectrum beta-lactamases in enterobacter species in the routine clinical setting	Stuart, J.C.; Diederen, B.; Al Naiemi, N.; Fluit, A.; Arents, N., et al
	2011	Protein binding: do we ever learn?	Zeitlinger, M.A.; Derendorf, H.; Mouton, J.W.; Cars, O.; Craig, W.A., et al
	2011	Update on antibacterial and antifungal drugs - can we master the resistance crisis?	Theuretzbacher, U.; Mouton, J.W.
	2011	Assessment of efficacy of antifungals in experimental models of invasive aspergillosis in an era of emerging resistance: the value of real-time quantitative PCR	Seyedmousavi, S.; Melchers, W.J.G.; Verweij, P.E.; Mouton, J.W.
	2011	Chlamydia antibody testing and diagnosing tubal pathology in subfertile women: an individual patient data meta-analysis	Broeze, K.A.; Opmeer, B.C.; Coppus, S.F.; Geloven, N. van; Alves, M.F., et al
	2011	Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole	Kuipers, S.; Bruggemann, R.J.M.; Sevaux, R.G. de; Heesakkers, J.P.F.A.; Melchers, W.J.G., et al
	2011	In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing	Rudramurthy, S.M.; Chakrabarti, A.; Geertsen, E.; Mouton, J.W.; Meis, J.F.G.M.
	2011	In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs	Shivaprakash, M.R.; Geertsen, E.; Chakrabarti, A.; Mouton, J.W.; Meis, J.F.G.M.
	2011	Relationship between pharmacodynamic indices and killing patterns in vitro	Mouton, J.W.
	2010	Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis.	Mavridou, E.; Bruggemann, R.J.M.; Melchers, W.J.G.; Verweij, P.E.; Mouton, J.W.
	2010	Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?	Chisholm, S.A.; Mouton, J.W.; Lewis, D.A.; Nichols, T.; Ison, C.A., et al
	2010	Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.	Mavridou, E.; Bruggemann, R.J.M.; Melchers, W.J.G.; Mouton, J.W.; Verweij, P.E.
	2010	Evaluation of Etest to determine tigecycline MICs for Enterobacter species.	Cohen Stuart, J.W.T.; Mouton, J.W.; Diederen, B.M.; Naiemi, N. Al; Thijsen, S., et al
	2010	Prevalence and molecular mechanism of macrolide resistance in beta-haemolytic streptococci in The Netherlands.	Buter, C.C.; Mouton, J.W.; Klaassen, C.H.; Handgraaf, C.M.; Sunnen, S., et al
	2010	Pharmacokinetics of clindamycin in pregnant women in the peripartum period	Muller, A.E.; Mouton, J.W.; Oostvogel, P.M.; Dorr, P.J.; Voskuyl, R.A., et al
	2008	Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.	Buijs, J.; Dofferhoff, A.S.M.; Mouton, J.W.; Wagenvoort, J.H.T.; Meer, J.W.M. van der
	2008	Therapeutic drug monitoring of voriconazole.	Bruggemann, R.J.M.; Donnelly, J.P.; Aarnoutse, R.E.; Warris, A.; Blijlevens, N.M.A., et al
	2008	In vitro activities at pH 5.0 and pH 7.0 and in vivo efficacy of flucytosine against Aspergillus fumigatus.	Verweij, P.E.; Dorsthorst, D.T.A. te; Janssen, W.H.P.; Meis, J.F.G.M.; Mouton, J.W.
	2008	Rapid and reliable identification of Streptococcus anginosus group isolates to the species level by real-time PCR and melting curve analysis.	Desar, I.M.E.; Boer, M. den; Bens, C.C.; Jacobs, J.A.; Mouton, J.W., et al
	2007	Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.	Buijs, J.; Dofferhoff, A.S.M.; Mouton, J.W.; Meer, J.W.M. van der
	2007	Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.	Rodriguez-Tudela, J.L.; Almirante, B.; Rodriguez-Pardo, D.; Laguna, F.; Donnelly, J.P., et al
	2007	A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA)	Voss, A.; Mouton, J.W.; Elzakker, E.P. van; Hendrix, R.G.; Goessens, W.H.F., et al
	2006	Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice.	Buijs, J.; Dofferhoff, A.S.M.; Mouton, J.W.; Meer, J.W.M. van der
	2006	Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation.	Mouton, J.W.; Peer, A. van; Beule, K. de; Vliet, A. van; Donnelly, J.P., et al
	2005	Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models.	Meletiadis, J.; Verweij, P.E.; Dorsthorst, D.T.A. te; Meis, J.F.G.M.; Mouton, J.W.
	2005	Relationship between in vitro activities of amphotericin B and flucytosine and pH for clinical yeast and mold isolates.	Dorsthorst, D.T.A. te; Verweij, P.E.; Meis, J.F.G.M.; Mouton, J.W.
	2005	In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the DUEL 2 study.	Neeleman, C.; Valk, J.A. de; Klaassen, C.H.W.; Meijers, S.; Mouton, J.W.
	2005	Duration of antibiotic treatment: are even numbers odd?	Alp, E.; Hoeven, J.G. van der; Verweij, P.E.; Mouton, J.W.; Voss, A.
	2005	Efficacy and pharmacodynamics of flucytosine monotherapy in a nonneutropenic murine model of invasive aspergillosis.	Dorsthorst, D.T.A. te; Verweij, P.E.; Meis, J.F.G.M.; Mouton, J.W.
	2004	In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models.	Dorsthorst, D.T.A. te; Verweij, P.E.; Meis, J.F.G.M.; Punt, N.C.; Mouton, J.W.
	2004	Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.	Dorsthorst, D.T.A. te; Mouton, J.W.; Beukel, C. van den; Lee, H.A.L. van der; Meis, J.F.G.M., et al
	2004	Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole.	Afeltra, J.; Vitale, R.G.; Mouton, J.W.; Verweij, P.E.
	2004	Pneumolysin is a key factor in misidentification of macrolide-resistant Streptococcus pneumoniae and is a putative virulence factor of S. mitis and other streptococci.	Neeleman, C.; Klaassen, C.H.W.; Klomberg, D.M.; Valk, H.A. de; Mouton, J.W.
	2004	Amplified fragment length polymorphism fingerprinting is an effective technique to distinguish streptococcus pneumoniae from other Streptococci and an efficient alternative to pulsed-field gel electrophoresis for molecular typing of pneumococci.	Neeleman, C.; Klaassen, C.H.W.; Valk, H.A. de; Ruiter, M.T. de; Mouton, J.W.
	2001	In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model	Stearne, L.E.T.; Gyssens, I.C.; Goessens, W.H.F.; Mouton, J.W.; Oyen, W.J.G., et al